Johnson & Johnson (NYSE:JNJ)
| 170.45 BATS BZX Real-Time Price As of 9:30am ET |  +0.23 / +0.14%Today’s Change | 133.65 Today|||52-Week Range 173.65 | +8.30% Year-to-Date |
Latest JNJ News | Press Releases
Today’s Trading
| Previous close | 170.22 |
| Today’s open | 171.53 |
| Day’s range | 170.12 - 171.61 |
| Volume | 163,212 |
| Average volume (3 months) | 8,012,437 |
| Market cap | $448.3B |
Data as of 9:30am ET, 05/17/2021
Growth & Valuation
| Earnings growth (last year) | -2.22% |
| Earnings growth (this year) | +19.67% |
| Earnings growth (next 5 years) | +6.40% |
| Revenue growth (last year) | +0.56% |
| P/E ratio | 30.1 |
| Price/Sales | 5.09 |
| Price/Book | 7.08 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| PFEPfizer | +0.06 | +0.15% |
| ABBVAbbVie | +0.43 | +0.37% |
| NVSNovartis | +0.04 | +0.04% |
| MRKMerck | +0.46 | +0.59% |
Data as of 9:30am ET, 05/17/2021
Financials
| Next reporting date | July 21, 2021 |
| EPS forecast (this quarter) | $2.29 |
| Annual revenue (last year) | $82.6B |
| Annual profit (last year) | $14.7B |
| Net profit margin | 17.82% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters New Brunswick, New Jersey |
Forecasts
